Gene · 8720
Papers2,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoxia activates SREBP2 through Golgi disassembly in bone marrow-derived monocytes for enhanced tumor growth. | EMBO J | 2023 | 37781951 | PubTator, text mining | PubMed |
| Segmented, Negative-Sense RNA Viruses of Humans: Genetic Systems and Experimental Uses of Reporter Strains. | Annu Rev Virol | 2023 | 37774125 | PubTator, text mining | PubMed |
| Adipose‑derived stem cell‑mediated alphastatin targeting delivery system inhibits angiogenesis and tumor growth in glioma. | Mol Med Rep | 2023 | 37772382 | PubTator, text mining | PubMed |
| How do immunocompromised people experience the changes in their working lives during the COVID-19 pandemic? Results from a mixed-methods study in Germany. | Heliyon | 2023 | 37771534 | PubTator, text mining | PubMed |
| The pathology of oxidative stress-induced autophagy in a chronic rotator cuff enthesis tear. | Front Physiol | 2023 | 37753454 | PubTator, text mining | PubMed |
| Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury. | Front Med (Lausanne) | 2023 | 37746079 | PubTator, text mining | PubMed |
| ER stress: an emerging regulator in GVHD development. | Front Immunol | 2023 | 37744326 | PubTator, text mining | PubMed |
| A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells. | Oncol Res | 2023 | 37744269 | PubTator, text mining | PubMed |
| A network meta-analysis of different acupuncture modalities in the treatment of bronchial asthma. | BMC Pulm Med | 2023 | 37740212 | PubTator, text mining | PubMed |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. | EClinicalMedicine | 2023 | 37731935 | PubTator, text mining | PubMed |
| Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application. | J Clin Transl Hepatol | 2023 | 37719956 | PubTator, text mining | PubMed |
| Mechanism of Polygonum capitatum intervention in pulmonary fibrosis based on network pharmacology and molecular docking technology: A review. | Medicine (Baltimore) | 2023 | 37713849 | PubTator, text mining | PubMed |
| A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model. | Nat Neurosci | 2023 | 37709997 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37709773 | PubTator, text mining | PubMed |
| Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms. | Nat Commun | 2023 | 37689782 | PubTator, text mining | PubMed |
| The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment. | Int J Mol Sci | 2023 | 37686409 | PubTator, text mining | PubMed |
| MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. | Int J Mol Sci | 2023 | 37686110 | PubTator, text mining | PubMed |
| Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology. | Int J Mol Sci | 2023 | 37686034 | PubTator, text mining | PubMed |
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica. | J Clin Med | 2023 | 37685618 | PubTator, text mining | PubMed |
| Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus. | PNAS Nexus | 2023 | 37674858 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8720/papers?page=17